Published in J Inherit Metab Dis on November 11, 2010
Options for basing Dietary Reference Intakes (DRIs) on chronic disease endpoints: report from a joint US-/Canadian-sponsored working group. Am J Clin Nutr (2016) 0.97
Modeling cellular compartmentation in one-carbon metabolism. Wiley Interdiscip Rev Syst Biol Med (2013) 0.94
Molecular mechanisms underlying the potentially adverse effects of folate. Clin Chem Lab Med (2013) 0.89
A nutrient-dense, high-fiber, fruit-based supplement bar increases HDL cholesterol, particularly large HDL, lowers homocysteine, and raises glutathione in a 2-wk trial. FASEB J (2012) 0.86
Relation of resistin levels with C-reactve protein, homocysteine and uric acid in smokers and non-smokers. J Res Med Sci (2011) 0.83
Multivitamin-mineral use is associated with reduced risk of cardiovascular disease mortality among women in the United States. J Nutr (2015) 0.83
Palm tocotrienol-rich fraction improves vascular proatherosclerotic changes in hyperhomocysteinemic rats. Evid Based Complement Alternat Med (2013) 0.82
Protein arginine methylation is more prone to inhibition by S-adenosylhomocysteine than DNA methylation in vascular endothelial cells. PLoS One (2013) 0.81
Intake of dietary folate and folic acid in Germany based on different scenarios for food fortification with folic acid. Eur J Nutr (2014) 0.80
Homocysteine lowering by folate-rich diet or pharmacological supplementations in subjects with moderate hyperhomocysteinemia. Nutrients (2013) 0.79
Homocysteine, grey matter and cognitive function in adults with cardiovascular disease. PLoS One (2012) 0.79
Plasma folate, but not homocysteine, is associated with Apolipoprotein A1 levels in a non-fortified population. Lipids Health Dis (2013) 0.79
Low-dose B vitamins supplementation ameliorates cardiovascular risk: a double-blind randomized controlled trial in healthy Chinese elderly. Eur J Nutr (2014) 0.78
Trends in clinical laboratory homocysteine testing from 1997 to 2010: the impact of evidence on clinical practice at a single institution. Clin Chem Lab Med (2013) 0.75
Potential Links between Impaired One-Carbon Metabolism Due to Polymorphisms, Inadequate B-Vitamin Status, and the Development of Alzheimer's Disease. Nutrients (2016) 0.75
Therapeutic potential of folic acid supplementation for cardiovascular disease prevention through homocysteine lowering and blockade in rheumatoid arthritis patients. Biomark Res (2015) 0.75
MicroRNA-130a alleviates human coronary artery endothelial cell injury and inflammatory responses by targeting PTEN via activating PI3K/Akt/eNOS signaling pathway. Oncotarget (2016) 0.75
Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med (2006) 11.72
A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA (1995) 11.45
Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med (2006) 9.53
Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J (1985) 9.28
Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA (2002) 8.11
Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA (2007) 7.93
Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med (2010) 6.48
Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med (1991) 6.03
Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol (1969) 5.01
Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet (2007) 4.74
The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet (1985) 4.60
Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. JAMA (2008) 4.49
HOMOCYSTINURIA: AN ENZYMATIC DEFECT. Science (1964) 3.63
Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr (2005) 3.45
HOMOCYSTINURIA: A NEW INBORN ERROR OF METABOLISM ASSOCIATED WITH MENTAL DEFICIENCY. Arch Dis Child (1963) 3.12
Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J Natl Cancer Inst (2003) 2.92
A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev (2007) 2.91
The identification of homocystine in the urine. Biochem Biophys Res Commun (1962) 2.82
Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst (2009) 2.64
Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr (2002) 2.52
Will mandatory folic acid fortification prevent or promote cancer? Am J Clin Nutr (2004) 2.19
Folate and risk of breast cancer: a meta-analysis. J Natl Cancer Inst (2007) 1.80
The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J Clin Invest (1976) 1.72
Vascular outcome in patients with homocystinuria due to cystathionine beta-synthase deficiency treated chronically: a multicenter observational study. Arterioscler Thromb Vasc Biol (2001) 1.71
Improvement in stroke mortality in Canada and the United States, 1990 to 2002. Circulation (2006) 1.58
Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies. J Cardiovasc Risk (1998) 1.43
Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials. Am Heart J (2006) 1.31
Plasma folate, vitamin B-6, vitamin B-12, and risk of breast cancer in women. Am J Clin Nutr (2008) 1.26
Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial. Am J Kidney Dis (2008) 1.03
VITATOPS, the VITAmins TO prevent stroke trial: rationale and design of a randomised trial of B-vitamin therapy in patients with recent transient ischaemic attack or stroke (NCT00097669) (ISRCTN74743444). Int J Stroke (2007) 0.84
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (2002) 40.37
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet (2009) 26.09
Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet (2008) 25.83
Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet (2008) 20.66
Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet (2007) 15.27
Major lipids, apolipoproteins, and risk of vascular disease. JAMA (2009) 10.58
Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med (2009) 8.73
Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med (2010) 6.48
UK health performance: findings of the Global Burden of Disease Study 2010. Lancet (2013) 6.11
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA (2009) 5.32
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet (2016) 4.49
Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals. Lancet (2013) 2.37
Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27,247 adults in 15 prospective studies. Int J Epidemiol (2006) 2.22
The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS One (2013) 1.95
A population-based cohort study of longer-term changes in health of car drivers involved in serious crashes. Ann Emerg Med (2006) 1.53
The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls. Eur Heart J (2009) 1.52
Physical activity and sedentary leisure time and their associations with BMI, waist circumference, and percentage body fat in 0.5 million adults: the China Kadoorie Biobank study. Am J Clin Nutr (2013) 1.51
Triggers of subarachnoid hemorrhage: role of physical exertion, smoking, and alcohol in the Australasian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS). Stroke (2003) 1.20
Alcohol consumption in 0.5 million people from 10 diverse regions of China: prevalence, patterns and socio-demographic and health-related correlates. Int J Epidemiol (2013) 1.20
Lymphotoxin-alpha gene and risk of myocardial infarction in 6,928 cases and 2,712 controls in the ISIS case-control study. PLoS Genet (2006) 1.16
Active and passive smoking and the risk of subarachnoid hemorrhage: an international population-based case-control study. Stroke (2004) 1.03
Coronary heart disease and body mass index: a systematic review of the evidence from larger prospective cohort studies. Semin Vasc Med (2002) 0.99
Obesity and health-related quality of life: results from a weight loss trial. N Z Med J (2004) 0.97
Blood pressure and coronary heart disease: a review of the evidence. Semin Vasc Med (2002) 0.95
Ethnicity and functional outcome after stroke. Stroke (2011) 0.94
Patterns and socio-demographic correlates of domain-specific physical activities and their associations with adiposity in the China Kadoorie Biobank study. BMC Public Health (2014) 0.92
Cholesterol, coronary heart disease and stroke: a review of published evidence from observational studies and randomized controlled trials. Semin Vasc Med (2002) 0.91
The association between homocysteine and myocardial infarction is independent of age, sex, blood pressure, cholesterol, smoking and markers of inflammation: the Glasgow Myocardial Infarction Study. Blood Coagul Fibrinolysis (2006) 0.88
Do n-of-1 trials really tailor treatment? Lancet (2005) 0.86
Homocysteine, renal function, and risk of cardiovascular disease. Kidney Int Suppl (2003) 0.85
Association between smoking and mortality: Khon Kaen cohort study, Thailand. Asian Pac J Cancer Prev (2013) 0.84
Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia. Curr Opin Clin Nutr Metab Care (2007) 0.83
Methodology of a population-based stroke and TIA incidence and outcomes study: the Auckland Regional Community Stroke Study (ARCOS IV) 2011-2012. Int J Stroke (2013) 0.80
Combined effects of systolic blood pressure and total cholesterol on cardiovascular disease risk. Circulation (2005) 0.79
Treatment of CML using IFN-alpha: impact on quality of life. Hematol J (2003) 0.79
Homocysteine and coronary heart disease. Semin Vasc Med (2002) 0.78
The associations of month of birth with body mass index, waist circumference, and leg length: findings from the China Kadoorie Biobank of 0.5 million adults. J Epidemiol (2015) 0.78
Survival in relation to angina symptoms and diagnosis among men aged 70-90 years: the Whitehall Study. Eur J Cardiovasc Prev Rehabil (2007) 0.78
Dicing with chance, life and death in systematic reviews and meta-analyses: D.I.C.E. 3, a simulation study. J R Soc Med (2014) 0.76
Surprising evidence about associations between body mass index and risks of coronary heart disease and stroke. Arch Intern Med (2002) 0.75
Alcohol consumption and mortality: the Khon Kaen Cohort Study, Thailand. J Epidemiol (2014) 0.75
Diurnal, weekly, and seasonal variations in stroke occurrence in a population-based study in Auckland, New Zealand. N Z Med J (2004) 0.75
Trans fatty acids and coronary heart disease. BMJ (2006) 0.75
Alcohol consumption in 0.5 million people from 10 diverse regions of China: prevalence, patterns and socio-demographic and health-related correlates. Int J Epidemiol (2017) 0.75
Determinants of major non-communicable diseases in the elderly: the pilot Freemasons health study. N Z Med J (2002) 0.75
[Seasonal variation of blood pressure and related factors in Chinese adults: a survey of over 50 000 people in Suzhou, China]. Zhonghua Liu Xing Bing Xue Za Zhi (2013) 0.75
Reducing recurrent stroke: methodology of the motivational interviewing in stroke (MIST) randomized clinical trial. Int J Stroke (2013) 0.75